* Clover Health Investments Corp CLOV.OQ CLOV.O is
expected
to show a rise in quarterly revenue when it reports results on
November 7.
* The Franklin Tennessee-based company is expected to
report a
87.2% increase in revenue to $799.463 million from $427.16
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 24 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $3, above its last closing price of $1.37.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.21 -0.21 -0.22 Missed -6.7
Mar. 31 2022 -0.28 -0.27 -0.19 Beat 30.5
Dec. 31 2021 -0.27 -0.26 -0.28 Missed -7.9
Sep. 30 2021 -0.24 -0.23 -0.08 Beat 65
Jun. -0.13 -0.14 -0.78 Missed -476.4
30 2021
Mar. 31 2021 -0.11 -0.11 -0.13 Missed -17.5
Dec. 31 2020 -0.84
This summary was machine generated November 5 at 03:14 GMT. All
figures in US dollars unless otherwise stated